Safety Study of ALG- 1001 to Treat Diabetic Macular Edema
NCT01482871
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
ALG-1001
DRUG:
ALG-1001
DRUG:
ALG-1001
DRUG:
ALG-1001
Sponsor
Allegro Ophthalmics, LLC